Group Revenue Growth (Full Year and Q4)
Full year 2025 net sales of ILS 12.5 billion, up 11.6% year-on-year; Q4 2025 net sales of ILS 3.2 billion, up 10.2% year-on-year, with broad-based growth across core segments.
Significant EBIT and Margin Improvement
Full year 2025 group EBIT reached a record ILS 1.02 billion, up 35.6% year-on-year with an 8.2% EBIT margin; Q4 2025 group EBIT was ILS 282 million, up 62.3% year-on-year with an 8.9% EBIT margin. Management cites 9.6% margins excluding the kitchen activity.
Coffee International: Outstanding Performance
Coffee International sales grew ~31% for the full year to ILS 6.2 billion and Q4 sales rose ~24% (ILS 1.6 billion); Coffee International EBIT more than doubled to ILS 493 million for the year, and Q4 EBIT jumped 270% to ILS 173 million (Q4 EBIT margin 10.9% vs 3.6% prior year).
Três Corações (Brazil) Record Results
Três Corações posted Q4 net sales of BRL 3.59 billion (+23.9% YoY) and Q4 EBIT of BRL 464 million (+364% YoY) with a 12.9% Q4 EBIT margin (vs 3.5% prior year). Full year 2025 sales BRL 14.1 billion and EBIT BRL 1.26 billion (+226% YoY), annual EBIT margin ~8.9%.
Turnaround to Positive Free Cash Flow
Free cash flow for Q4 2025 was ILS 554 million (up ILS 110 million YoY). Full year free cash flow turned positive to ILS 215 million versus negative ILS 51 million in the prior reported period, driven by higher profitability and lower CapEx.
Productivity and Cost-Savings Progress
Management remains on track (and expects to exceed) productivity targets in the range of ILS 300–400 million, contributing materially to improved operational profit and margin recovery.
Strategic M&A and Scale Gains (Yoki)
Acquisition of Yoki in Brazil at ~0.4x revenues aligned with strategy to leverage local brands; expected synergies include distribution expansion (from ~100k to ~400k points), logistics and SG&A consolidation, with a target turnaround within 18–24 months.
Innovation and Capacity Expansion
Multiple innovations and launches (e.g., carb-free drinks, expanded protein offerings) and new capacity: a plant for alternative milks in northern Israel launched in Oct 2025 and additional lines to address capacity constraints to meet demand.
Improved Leverage Metrics
Net debt ended at ILS 2.2 billion and net debt-to-EBITDA improved to 1.6x (from 1.7x a year ago), indicating moderate leverage and an improved balance sheet posture.